{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:38:42Z","timestamp":1775666322077,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Cairo university funds","award":["10.000 LE"],"award-info":[{"award-number":["10.000 LE"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jns.2016.07.034","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:16:36Z","timestamp":1468800996000},"page":"36-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients"],"prefix":"10.1016","volume":"369","author":[{"given":"Tarek Z.","family":"Tawfik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel H.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina A.","family":"Mehaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4998-4621","authenticated-orcid":false,"given":"Eslam","family":"El Nahrery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem S.","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebatalla","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawal F. Abdel","family":"Ghaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevin","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.07.034_bb0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.07.034_bb0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000324035","article-title":"Patterns of TH1\/TH2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetate","volume":"65","author":"Tumani","year":"2011","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2016.07.034_bb0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1352458510393772","article-title":"Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study","volume":"17","author":"Veauthier","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2016.07.034_bb0020","doi-asserted-by":"crossref","first-page":"12656","DOI":"10.3390\/ijms131012656","article-title":"Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing\u2013remitting multiple sclerosis patients","volume":"13","author":"Reale","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2016.07.034_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-215","article-title":"Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis","volume":"vol. 9","author":"Christensen Romme","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jns.2016.07.034_bb0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jns.2016.07.034_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2478\/v10153-010-0034-x","article-title":"Clinical and laboratory study of pro-inflammatory and anti-inflammatory cytokines in women with multiple sclerosis","volume":"53","author":"Trenova","year":"2011","journal-title":"Folia Med (Plovdiv)"},{"issue":"5","key":"10.1016\/j.jns.2016.07.034_bb0040","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbi.2010.08.004","article-title":"IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection","volume":"25","author":"Xina","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.jns.2016.07.034_bb0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.exger.2012.11.001","article-title":"Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age","volume":"48","author":"Sikka","year":"2013","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jns.2016.07.034_bb0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.07.034_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.03.026","article-title":"Biomarkers of disease activity in multiple sclerosis","volume":"305","author":"Graber","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2016.07.034_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2014.12.005","article-title":"A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis","volume":"278","author":"Pasqualia","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2016.07.034_bb0065","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3892\/mmr.2013.1256","article-title":"Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease","volume":"7","author":"Kallaur","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jns.2016.07.034_bb0070","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.clineuro.2008.06.005","article-title":"Effect of treatment with methylprednisolone on serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse","volume":"110","author":"Rentzosa","year":"2008","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2016.07.034_bb0075","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bcp.2008.11.011","article-title":"Interleukin 17 sustains rather than induces inflammation","volume":"77","author":"Maione","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2016.07.034_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2011.12.008","article-title":"Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis","volume":"243","author":"Chen","year":"2012","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16304476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16304476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T04:20:51Z","timestamp":1568175651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16304476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":16,"alternative-id":["S0022510X16304476"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.07.034","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}